The Indiana Office of Utility Consumer Counselor is inviting written comments from Indianapolis Power & Light customers about the utility’s pending request to raise electricity prices.
Announcements Community Solutions Inc., an Indianapolis-based human service and community development-consulting firm, is accepting applications for their 2015 Pro Bono client. Applicants must come from 501(c) (3) community-based organizations with agency budgets under $500,000 that have been operational for at least three years. The selected client will receive 120 hours of free services provided over a […]
A Cuban immigrant was sentenced Wednesday to more than six years in prison for his role in the 2010 heist of a Connecticut warehouse in which the robbers filled a tractor-trailer with more than $50 million worth of Eli Lilly and Co. pharmaceuticals.
More medical malpractice cases could be filed directly in state trial courts without first having to go through the mandatory medical review process, under legislation pending in the Indiana Senate. Senate Bill 55, which cleared the Senate Judiciary Committee Jan. 21, raises the dollar amount of malpractice claims exempt from the medical review panel process […]
Eli Lilly and Co. predicted its 2015 sales will come in roughly $1 billion less than analysts have expected, due to the strength of the U.S. dollar against foreign currencies.
Indiana won’t put itself on the marijuana-friendly map this year, as a medical marijuana bill authored by Democratic Sen. Karen Tallian is unlikely to go further than a committee hearing.
Jason Riley, 34, director of human resources and global talent development at Hillenbrand Inc., embraced his company’s global outlook as a talent-development tool.
Novartis AG is racing to establish itself in the market for new treatments for psoriasis ahead of competing drugs by Amgen Inc. and Eli Lilly and Co. in the United States.
The CEOs of Anthem, Lilly, Zimmer and Hill-Rom tried to woo investors at the J.P. Morgan Healthcare conference by stressing how they’re broadening business beyond plain-old insurance, pharmaceuticals, implants and hospital beds.
Eli Lilly and Co. is trying to play catch-up in the hot trend of fighting cancer by targeting the body’s immune system. According to Reuters, Indianapolis-based Lilly signed two separate deals with New Jersey-based Merck & Co. Inc. and New York-based Bristol-Myers Squibb Co. to pair their newly approved “immune-oncology” drugs with Lilly’s cancer drugs. […]
The game has become a must-have-reservations attraction in the historic Fountain Square neighborhood and one of Indy's most original activities for corporate team-building, date night or a fun time out with friends.
The Food and Drug Administration acknowledged the mistake Friday in an e-mail and said it removed Indianapolis-based Lilly’s name from an import alert that attributed the pills to the company’s office in Australia.
Health-coverage managers are becoming more aggressive in demanding discounts and exclusive deals from drugmakers to drive down the cost of medicine, Eli Lilly and Co.’s diabetes business chief says.
A batch of Cialis pills, purportedly made at a plant in Australia, was banned by the FDA from entering the U.S. after the pills were found to contain the active ingredient for rival drug Viagra. Cialis manufacturer Eli Lilly said it doesn’t make any drugs in Australia.
Since Obamcare was expected to boost insurance coverage nationally by 32 million people, drugmakers like Eli Lilly and Co. stood to benefit. But it’s not working out that way. At least not for Lilly.
The Indianapolis-based drugmaker said its long-term strategy is on track, but predicted sales this year would be $20.3 billion to $20.8 billion, a shade below what Wall Street was expecting.
